Clinical Trials

SRC8: A Randomized Phase III Trial of Doxorubicin + Pembrolizumab versus Doxorubicin Alone for the Treatment of Undifferentiated Pleomorphic Sarcoma (UPS) and Related Poorly Differentiated Sarcomas

Link : https://clinicaltrials.gov/ct2/show/NCT06422806
Status : RECRUITING
Population : mDDLPS - first line setting mUPS cohort now closed
Description : DDLPS 1st line: Dox + pembro vs. Dox
PI : A. Salawu
Centers Opened : PMH
Phase : III
IIST/Pharma : CCTG